- Home
- GRFS vs UGI Comparison
GRFS vs UGI Comparison
Compare GRFS & UGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRFS
- UGI
- Stock Information
- Founded
- GRFS 1940
- UGI 1940
- Country
- GRFS Spain
- UGI United States
- Employees
- GRFS N/A
- UGI N/A
- Industry
- GRFS Biotechnology: Pharmaceutical Preparations
- UGI Natural Gas Distribution
- Sector
- GRFS Health Care
- UGI Utilities
- Exchange
- GRFS Nasdaq
- UGI Nasdaq
- Market Cap
- GRFS 7.2B
- UGI 7.4B
- IPO Year
- GRFS 2006
- UGI N/A
- Fundamental
- Price
- GRFS $9.87
- UGI $33.34
- Analyst Decision
- GRFS Hold
- UGI Buy
- Analyst Count
- GRFS 1
- UGI 3
- Target Price
- GRFS $10.30
- UGI $31.33
- AVG Volume (30 Days)
- GRFS 489.5K
- UGI 1.6M
- Earning Date
- GRFS 01-01-0001
- UGI 08-06-2025
- Dividend Yield
- GRFS 1.47%
- UGI 4.39%
- EPS Growth
- GRFS 132.60
- UGI N/A
- EPS
- GRFS 0.53
- UGI 1.92
- Revenue
- GRFS $8,744,226,659.00
- UGI $7,332,000,000.00
- Revenue This Year
- GRFS $6.00
- UGI $10.33
- Revenue Next Year
- GRFS $6.71
- UGI $16.58
- P/E Ratio
- GRFS $24.37
- UGI $17.82
- Revenue Growth
- GRFS 9.32
- UGI N/A
- 52 Week Low
- GRFS $6.19
- UGI $23.14
- 52 Week High
- GRFS $11.14
- UGI $37.43
- Technical
- Relative Strength Index (RSI)
- GRFS 47.26
- UGI 34.19
- Support Level
- GRFS $9.63
- UGI $34.08
- Resistance Level
- GRFS $10.14
- UGI $34.96
- Average True Range (ATR)
- GRFS 0.18
- UGI 0.49
- MACD
- GRFS -0.02
- UGI -0.04
- Stochastic Oscillator
- GRFS 46.15
- UGI 6.31
About GRFS Grifols S.A.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
About UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.